Current Liabilities
Accrued Manufacturing Costs
Incyte Accrued Manufacturing Costs decreased by 45.2% to $124.92M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.5%, from $102.82M to $124.92M. Over 5 years (FY 2020 to FY 2025), Accrued Manufacturing Costs shows an upward trend with a 15.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2014
Last reportedQ1 2026Apr 28, 2026
Metric ID:
accrued_manufacturing_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.76M | $105.71M | $108.96M | $83.66M | $93.15M | $106.31M | $138.76M | $84.72M | $111.71M | $124.78M | $153.35M | $89.11M | $113.54M | $150.72M | $188.68M | $102.82M | $129.11M | $168.25M | $228.07M | $124.92M |
| QoQ Change | — | +27.7% | +3.1% | -23.2% | +11.3% | +14.1% | +30.5% | -38.9% | +31.9% | +11.7% | +22.9% | -41.9% | +27.4% | +32.8% | +25.2% | -45.5% | +25.6% | +30.3% | +35.6% | -45.2% |
| YoY Change | — | — | — | — | +12.5% | +0.6% | +27.3% | +1.3% | +19.9% | +17.4% | +10.5% | +5.2% | +1.6% | +20.8% | +23.0% | +15.4% | +13.7% | +11.6% | +20.9% | +21.5% |
Range$82.76M – $228.07M
CAGR+9.1%
Avg YoY Growth+14.0%
Median YoY Growth+14.6%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is Incyte's accrued manufacturing costs?
- Incyte (INCY) reported accrued manufacturing costs of $124.92M in Q1 2026.
- How has Incyte's accrued manufacturing costs changed year-over-year?
- Incyte's accrued manufacturing costs increased by 21.5% year-over-year, from $102.82M to $124.92M.
- What is the long-term trend for Incyte's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Incyte's accrued manufacturing costs has grown at a 15.0% compound annual growth rate (CAGR), from $113.34M to $228.07M.